{"transactions":[{"id":866721,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:27.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-26-007644","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007644/form4.xml","form_type":"4"}},{"id":1081373,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"officer":true,"officer_title":"Chief Operations Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:47.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027400","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027400/form4.xml","form_type":"4"}},{"id":1530495,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"officer":true,"officer_title":"Chief Operations Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-05-02T20:17:34.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on May 1, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":3.61,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-24-024002","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124024002/form4.xml","form_type":"4"}},{"id":4323110,"issuer":{"id":176222,"kind":"organization","name":"INTERLEUKIN GENETICS INC","symbol":"ILIU"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-12T14:51:47.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":182547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on April 19, 2017, which was the grant date of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on April 19, 2018, and 1/36th of the shares on the first day of each month beginning on May 1, 2018."}],"balance_after":182547,"derivative":{"exercise_price":0.095,"expiration_date":"2027-04-19","underlying":"Common Stock","underlying_shares":182547},"source":{"system":"sec-edgar","filing":"0001144204-17-026826","document":"v466930_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037649/000114420417026826/v466930_form4.xml","form_type":"4"}},{"id":4480753,"issuer":{"id":176222,"kind":"organization","name":"INTERLEUKIN GENETICS INC","symbol":"ILIU"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-26T17:56:44.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":365093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on January 25, 2017, which was the grant date of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on January 25, 2018, and 1/36th of the shares on the first day of each month beginning on February 1, 2018."}],"balance_after":365093,"derivative":{"exercise_price":0.1237,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":365093},"source":{"system":"sec-edgar","filing":"0001144204-17-004094","document":"v457637_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037649/000114420417004094/v457637_form4.xml","form_type":"4"}},{"id":4576221,"issuer":{"id":176222,"kind":"organization","name":"INTERLEUKIN GENETICS INC","symbol":"ILIU"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-21T16:05:19.000Z","date":"2016-10-20","kind":"grant","acquired":true,"shares":3738933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on October 20, 2016, which was the grant date of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on August 15, 2017, and 1/36th of the shares on the first day of each month beginning on September 1, 2017."}],"balance_after":3738933,"derivative":{"exercise_price":0.1754,"expiration_date":"2026-10-20","underlying":"Common Stock","underlying_shares":3738933},"source":{"system":"sec-edgar","filing":"0001144204-16-128961","document":"v450889_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037649/000114420416128961/v450889_4.xml","form_type":"4"}}]}